Wedge Capital Management L L P NC Decreases Stock Holdings in Cigna Group $CI

Wedge Capital Management L L P NC lessened its stake in shares of Cigna Group (NYSE:CI) by 12.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 25,514 shares of the health services provider’s stock after selling 3,672 shares during the quarter. Wedge Capital Management L L P NC’s holdings in Cigna Group were worth $7,022,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Pathway Financial Advisers LLC boosted its holdings in Cigna Group by 2.3% in the second quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock worth $496,000 after purchasing an additional 34 shares during the last quarter. Armstrong Advisory Group Inc. lifted its holdings in shares of Cigna Group by 17.7% during the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock valued at $65,000 after buying an additional 34 shares during the period. HM Payson & Co. lifted its holdings in shares of Cigna Group by 0.9% during the 3rd quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock valued at $1,091,000 after buying an additional 35 shares during the period. Carr Financial Group Corp boosted its stake in shares of Cigna Group by 5.3% in the 3rd quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock worth $204,000 after buying an additional 36 shares during the last quarter. Finally, Natural Investments LLC boosted its stake in shares of Cigna Group by 2.0% in the 3rd quarter. Natural Investments LLC now owns 1,843 shares of the health services provider’s stock worth $531,000 after buying an additional 36 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Barclays reduced their price objective on Cigna Group from $305.00 to $303.00 and set an “overweight” rating for the company in a research report on Friday, February 6th. Sanford C. Bernstein upgraded Cigna Group from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $307.00 to $358.00 in a research note on Thursday, March 12th. TD Cowen upped their price target on shares of Cigna Group from $333.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, February 9th. Jefferies Financial Group increased their price objective on shares of Cigna Group from $310.00 to $333.00 and gave the stock a “buy” rating in a research note on Monday, February 9th. Finally, Piper Sandler dropped their price objective on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $333.11.

Cigna Group Price Performance

Shares of Cigna Group stock opened at $261.98 on Friday. The stock has a market cap of $69.04 billion, a P/E ratio of 11.81, a P/E/G ratio of 0.91 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The stock’s fifty day moving average is $277.10 and its 200 day moving average is $280.31. Cigna Group has a one year low of $239.51 and a one year high of $350.00.

Cigna Group (NYSE:CI) last released its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same quarter in the previous year, the company posted $6.64 earnings per share. Cigna Group’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Thursday, March 5th were issued a $1.56 dividend. The ex-dividend date of this dividend was Thursday, March 5th. This represents a $6.24 annualized dividend and a yield of 2.4%. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is currently 28.13%.

Insider Activity at Cigna Group

In other Cigna Group news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.